CymaBay Therapeutics, Inc.
USD32.48
+0.01 (+0.03%)
CEO
Sujal A. Shah
IPO Date
2014-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.49
Prev. Close
$32.47
Day Low
$32.48
Day High
$32.50
52W Low
$7.26
52W High
$32.50
Market Cap
$3.73B
Volume
8.35M
| -4.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -69.6% | -45.8% | 0.39 | 10.41 | -2.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -34.1% | -31.6% | 0.01 | 15.38 | -8.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -54.9% | -49.7% | 0.01 | 11.51 | -1.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -42.6% | -38.8% | 0.00 | 12.60 | -6.3 |
| 31 Dec 2017 | FY | 100.0% | -275.6% | -32.4% | -26.4% | 0.07 | 6.35 | -11.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -677.4% | -137.8% | 2.23 | 1.99 | -1.5 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -55.2% | -36.0% | 0.33 | 6.96 | -2.1 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -230.4% | -85.2% | 0.33 | 1.82 | -3.7 |
| -11.6 |
| 30 Jun 2023 | Q2 | 99.3% | -2.6% | -0.7% | -0.4% | 0.92 | 12.52 | -346.1 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -33.7% | -14.3% | 0.91 | 5.22 | -6.1 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -100.6% | -25.6% | 2.51 | 8.94 | -3.8 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -45.9% | -17.4% | 1.45 | 12.20 | -2.7 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -36.9% | -17.1% | 1.01 | 13.27 | -2.1 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -28.9% | -15.5% | 0.74 | 13.68 | -2.2 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -20.0% | -13.1% | 0.39 | 10.41 | -2.2 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -26.1% | -18.5% | 0.28 | 10.18 | -2.8 |